Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Synergistic Ultrasound Platform Advances Breast Imaging

By HospiMedica International staff writers
Posted on 18 Jan 2021
A new quantitative transmission ultrasound imaging system provides reflection-mode and transmission-mode images of a patient's breasts. More...


The QT Imaging (Novato, CA, USA) QTscan is a non-invasive breast imaging tool that uses a transmitter/receiver array pair for complementary transmission and reflection ultrasound in order to generate highly accurate three dimensional (3D) volumetric ultrasound images. QTscan consists of a patient support table and a scan tank filled with warm water that holds the ultrasound transducer arrays, and an additional transmitter and receiver array pair to collect ultrasound energy for speed of sound (SOS) values.

The transducer array includes three reflectors that transmit pulsed ultrasound plane waves into targeted tissues, with the water bath in the scan tank as a coupling medium. During scanning, the patient lies prone face down on the support table with the breast suspended in the scan bath, with the nipple as a point of reference. The transducer arrays rotate about a vertical axis to circle the breast in the coronal plane. The array then translates vertically and the scanning process is repeated until the entire breast is scanned.

The QTscan then outputs the B-scan images to be constructively combined into tomographic, SOS, and reflection ultrasound images, which can be viewed on the proprietary QTviewer in coronal, axial, and sagittal sections. SOS images may be queried by probe and region of interest (ROI) tools provided in the viewer console that provide SOS values in meters/sec to aid in the diagnostic evaluation of the breast.

“The QTscan allows for painless breast imaging, as no compression is required, with no need for x-ray radiation (such as in mammography) and no need for administration of contrast agents, as required for the majority of breast MRI scans,” said the company. “It is intended to be used as an initial evaluation method for asymptomatic women identified with above-average risk for developing breast cancer, based on genetic testing or other established criteria. It is not intended to be used as a replacement for standard screening mammography.”

Related Links:
QT Imaging


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Infant Resuscitator
Easypuff
Imaging Table
Stille imagiQ2
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.